476040 — OrganoidSciences Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapSucker Stock

Annual cashflow statement for OrganoidSciences, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	PROSPECTUS	PROSPECTUS	PROSPECTUS	PROSPECTUS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	-17,615	-24,111	-38,868	-11,536	-15,739
Depreciation
Amortisation
Non-Cash Items	12,478	14,390	30,441	827	898
Unusual Items
Other Non-Cash Items
Changes in Working Capital	-84.1	399	34.8	264	-593
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Accounts Payable
Change in Accrued Expenses
Change in Taxes Payable
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities	-4,959	-8,518	-7,248	-9,141	-13,989
Capital Expenditures	-3,932	-1,804	-1,018	-787	-1,964
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	-52.8	-26,528	5,618	5,713	-6,218
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities	-3,984	-28,332	4,600	4,925	-8,182
Financing Cash Flow Items	132	218	148	281	644
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	32,722	11,286	180	3,663	25,407
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	23,779	-25,563	-2,543	-507	3,292